Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives.

Daily K, Ho Sui SJ, Schriml LM, Dexheimer PJ, Salomonis N, Schroll R, Bush S, Keddache M, Mayhew C, Lotia S, Perumal TM, Dang K, Pantano L, Pico AR, Grassman E, Nordling D, Hide W, Hatzopoulos AK, Malik P, Cancelas JA, Lutzko C, Aronow BJ, Omberg L.

Sci Data. 2017 Mar 28;4:170030. doi: 10.1038/sdata.2017.30.

2.

Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency.

Nasimuzzaman M, Lynn D, Ernst R, Beuerlein M, Smith RH, Shrestha A, Cross S, Link K, Lutzko C, Nordling D, Russell DW, Larochelle A, Malik P, Van der Loo JC.

Mol Ther Methods Clin Dev. 2016 Mar 16;3:16004. eCollection 2016.

3.

Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.

van der Loo JC, Swaney WP, Grassman E, Terwilliger A, Higashimoto T, Schambach A, Hacein-Bey-Abina S, Nordling DL, Cavazzana-Calvo M, Thrasher AJ, Williams DA, Reeves L, Malik P.

Gene Ther. 2012 Aug;19(8):872-6. doi: 10.1038/gt.2012.37. Epub 2012 May 3.

4.

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

van der Loo JC, Swaney WP, Grassman E, Terwilliger A, Higashimoto T, Schambach A, Baum C, Thrasher AJ, Williams DA, Nordling DL, Reeves L, Malik P.

Gene Ther. 2012 Mar;19(3):246-54. doi: 10.1038/gt.2011.102. Epub 2011 Jul 14.

5.

Release testing of retroviral vectors and gene-modified cells.

Nordling D, Kaiser A, Reeves L.

Methods Mol Biol. 2009;506:265-79. doi: 10.1007/978-1-59745-409-4_18. Review.

PMID:
19110632
6.

Infectious diseases, reproductive effort and the cost of reproduction in birds.

Gustafsson L, Nordling D, Andersson MS, Sheldon BC, Qvarnström A.

Philos Trans R Soc Lond B Biol Sci. 1994 Nov 29;346(1317):323-31.

PMID:
7708827

Supplemental Content

Loading ...
Support Center